HAM
ANIK icon

Highstreet Asset Management’s Anika Therapeutics ANIK Stock Holding History

Highstreet Asset Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2K Buy
47
+15
+47% +$871 ﹤0.01% 581
2019
Q3 		$2K Buy
+32
New +$1.64K ﹤0.01% 348

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Highstreet Asset Management's ANIK Position: Q4 2019 in Review

Highstreet Asset Management increased its Anika Therapeutics (ANIK) stake by 47% in Q4 2019, buying an estimated $871 and bringing the position to 47 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #581.

Highstreet Asset Management first reported a position in ANIK in Q3 2019 and has held it in 2 quarters since. 191 funds tracked by Wall St. Rank hold ANIK as of Q4 2019.

  • Highstreet Asset Management held 47 shares of Anika Therapeutics worth $2K as of Q4 2019.
  • Highstreet Asset Management bought 15 Anika Therapeutics shares in Q4 2019, an estimated $871.
  • Anika Therapeutics made up ﹤0.01% of Highstreet Asset Management's portfolio in Q4 2019, its #581 holding.
  • Highstreet Asset Management first reported a position in Anika Therapeutics in Q3 2019 and has held it in 2 quarters since.
  • 191 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2019.

Based on Highstreet Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.